• Clinical activity of futibatinib in currently studied areas with(out) combinations based on mechanistic rationale
  • Clinical activity of futibatinib with(out) combinations in new disease areas with unmet medical need that are not currently part of the futibatinib development plan
  • Quality of life, safety management (including compliance, dosing, etc.) and health care resource utilization with futibatinib in the real world
  • Pre-clinical activity of futibatinib to further support current clinical development plan and/or support rationale for use in new clinical settings